Autoimmune pemphigus: latest advances and emerging therapies
Pemphigus represents a group of rare and severe autoimmune intra-epidermal blistering
diseases affecting the skin and mucous membranes. These painful and debilitating diseases …
diseases affecting the skin and mucous membranes. These painful and debilitating diseases …
Comprehensive review on the pathophysiology, clinical variants and management of pemphigus
Pemphigus represents a group of chronic inflammatory disorders characterized by
autoantibodies that target components of desmosomes, leading to the loss of intercellular …
autoantibodies that target components of desmosomes, leading to the loss of intercellular …
[HTML][HTML] Beyond the HLA polymorphism: a complex pattern of genetic susceptibility to pemphigus
ML Petzl-Erler - Genetics and molecular biology, 2020 - SciELO Brasil
Pemphigus is a group of autoimmune bullous skin diseases that result in significant
morbidity. As for other multifactorial autoimmune disorders, environmental factors may …
morbidity. As for other multifactorial autoimmune disorders, environmental factors may …
Targeting inducible costimulator expressed on CXCR5+ PD-1+ TH cells suppresses the progression of pemphigus vulgaris
AR Kim, D Han, JY Choi, J Seok, SE Kim… - Journal of Allergy and …, 2020 - Elsevier
Background Pemphigus vulgaris (PV) is an autoimmune bullous disease mediated by
autoantibodies against desmoglein 3 (DSG3). Inducible costimulator (ICOS) is a …
autoantibodies against desmoglein 3 (DSG3). Inducible costimulator (ICOS) is a …
Insights into the host contribution of endocrine associated immune-related adverse events to immune checkpoint inhibition therapy
A Chye, I Allen, M Barnet, DL Burnett - Frontiers in Oncology, 2022 - frontiersin.org
Blockade of immune checkpoints transformed the paradigm of systemic cancer therapy,
enabling substitution of a cytotoxic chemotherapy backbone to one of immunostimulation in …
enabling substitution of a cytotoxic chemotherapy backbone to one of immunostimulation in …
Genetic variability of immune‐related lncRNAs: polymorphisms in LINC‐PINT and LY86‐AS1 are associated with pemphigus foliaceus susceptibility
A Salviano‐Silva, TDJ Farias… - Experimental …, 2021 - Wiley Online Library
Pemphigus foliaceus (PF) is an autoimmune blistering disease of the skin, clinically
characterized by erosions and, histopathologically, by acantholysis. PF is endemic in the …
characterized by erosions and, histopathologically, by acantholysis. PF is endemic in the …
Impact of population admixture on the distribution of immune response co-stimulatory genes polymorphisms in a Brazilian population
GC Cassiano, EJM Santos, MHT Maia… - Human Immunology, 2015 - Elsevier
Co-stimulatory molecules are essential in the orchestration of immune response and
polymorphisms in their genes are associated with various diseases. However, in the case of …
polymorphisms in their genes are associated with various diseases. However, in the case of …
Long noncoding RNA polymorphisms influence susceptibility to endemic pemphigus foliaceus
SC Lobo‐Alves, DG Augusto… - British Journal of …, 2019 - academic.oup.com
Background Pemphigus foliaceus (PF) is an epidermal autoimmune disease, characterized
by the presence of autoantibodies against the desmosomal protein desmoglein 1. Genetic …
by the presence of autoantibodies against the desmosomal protein desmoglein 1. Genetic …
Screening the full leucocyte receptor complex genomic region revealed associations with pemphigus that might be explained by gene regulation
Pemphigus foliaceus (PF) is a blistering autoimmune skin disease rare in most of the world
but endemic in certain regions of Brazil. PF is characterized by the detachment of epidermal …
but endemic in certain regions of Brazil. PF is characterized by the detachment of epidermal …
Sparking fire under the skin? Answers from the association of complement genes with pemphigus foliaceus
V Bumiller-Bini, GA Cipolla, RC De Almeida… - Frontiers in …, 2018 - frontiersin.org
Skin blisters of pemphigus foliaceus (PF) present concomitant deposition of autoantibodies
and components of the complement system (CS), whose gene polymorphisms are …
and components of the complement system (CS), whose gene polymorphisms are …